The pharmaceutical industry is a key partner in Europe’s fight against disease, developing new treatments and cures for patients across Europe. It is imperative that Europe remains a competitive destination for medical research and development by maintaining, sustaining and developing a predictable, robust regulatory and innovation-supportive incentives environment.
Source: European Federation of Pharmaceutical Industries and Associations
As it reaches its final year, Horizon 2020 continues to support research and innovation projects across the European Union. How has it helped advance the bloc’s rail infrastructure, what have its successes been and what more can be expected?